Last €0.51 EUR
Change Today +0.007 / 1.40%
Volume 0.0
C33 On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 3:03 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

ceres inc (C33) Snapshot

Open
€0.49
Previous Close
€0.50
Day High
€0.51
Day Low
€0.49
52 Week High
07/22/13 - €1.61
52 Week Low
05/9/14 - €0.34
Market Cap
24.4M
Average Volume 10 Days
220.0
EPS TTM
--
Shares Outstanding
48.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CERES INC (C33)

ceres inc (C33) Related Businessweek News

No Related Businessweek News Found

ceres inc (C33) Details

Ceres, Inc., an agricultural biotechnology company, develops and sells energy crops to produce renewable bioenergy feedstocks in North America. The company energy crops include sweet sorghum; high biomass sorghum for the generation of renewable electric power and the creation of cellulosic biofuels; switchgrass, a perennial grass; miscanthus, a tall perennial grass for use as an energy crop. Ceres, Inc. markets its seed varieties and traits under the Blade Energy Crops and Blade brands. The company sells and distributes its seed products to ethanol mills, utilities, independent power producers, cellulosic biofuel companies, individual growers, and grower cooperatives. The company was founded in 1996 and is headquartered in Thousand Oaks, California.

85 Employees
Last Reported Date: 03/5/14
Founded in 1996

ceres inc (C33) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $466.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $323.0K
Compensation as of Fiscal Year 2013.

ceres inc (C33) Key Developments

Ceres, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended May 31, 2014

Ceres, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended May 31, 2014. For the quarter, the company reported total revenues of $806,000 against $1,355,000 a year ago. Loss from operations was $7,715,000 against $9,317,000 a year ago. Loss before income taxes was $7,727,000 against $9,323,000 a year ago. Net loss was $7,727,000 or $0.17 per basic and diluted share against $9,323,000 or $0.38 per basic and diluted share a year ago. For the nine months, the company reported total revenues of $2,064,000 against $4,346,000 a year ago. Loss from operations was $23,151,000 against $25,252,000 a year ago. Loss before income taxes was $23,156,000 against $25,181,000 a year ago. Net loss was $23,157,000 or $0.72 per basic and diluted share against $25,182,000 or $1.02 per basic and diluted share a year ago.

Ceres, Inc. Licenses its Persephone Genome Visualization Application to Bayer CropScience

Ceres, Inc. announced that the company has licensed its Persephone genome visualization application to Bayer CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance. Originally developed for in-house use by Ceres, Persephone allows researchers to rapidly zoom in and out of massive amounts of genetic data, from a chromosome level to a single building block of DNA. On top of this data, users can layer and cross reference related information in much the same way geographic mapping services allow users to add weather information or business locations to a geographic map.

Ceres, Inc. to Report Q3, 2014 Results on Jul 10, 2014

Ceres, Inc. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Jul 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
C33:GR €0.51 EUR +0.007

C33 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $3.66 USD +0.04
Monsanto Co $119.73 USD +0.77
Viaspace Inc $0.01 USD -0.0005
View Industry Companies
 

Industry Analysis

C33

Industry Average

Valuation C33 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.8x
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERES INC, please visit www.ceres.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.